MELBOURNE, July 12 (Reuters) - Embattled Australian drug maker Sigma Pharmaceuticals wants South Africa's Aspen Pharmacare to improve its A$648 million ($567 million) bid but declined to extend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback